chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lower extremity swelling around groin; lower extremity swelling around the knees; lower extremety swelling around lymph nodes,swelling was pronounced at the lymph nodes around groin and knees; total body arthritic pain,arthritic pain was most  pronounced around my pelvis and knees; low grade fever; headache; body aches; chills; This spontaneous case was reported by a nurse and describes the occurrence of SWELLING (lower extremity swelling around groin), JOINT SWELLING (lower extremity swelling around the knees), LYMPHADENOPATHY (lower extremety swelling around lymph nodes,swelling was pronounced at the lymph nodes around groin and knees), ARTHRALGIA (total body arthritic pain,arthritic pain was most  pronounced around my pelvis and knees) and PYREXIA (low grade fever) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     It was reported that the patient had no medical issues before receiving the Moderna COVID-19 vaccine.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced SWELLING (lower extremity swelling around groin), JOINT SWELLING (lower extremity swelling around the knees), LYMPHADENOPATHY (lower extremety swelling around lymph nodes,swelling was pronounced at the lymph nodes around groin and knees), ARTHRALGIA (total body arthritic pain,arthritic pain was most  pronounced around my pelvis and knees), PYREXIA (low grade fever), HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills). On 18-Jan-2021, PYREXIA (low grade fever), HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills) had resolved. At the time of the report, SWELLING (lower extremity swelling around groin), JOINT SWELLING (lower extremity swelling around the knees), LYMPHADENOPATHY (lower extremety swelling around lymph nodes,swelling was pronounced at the lymph nodes around groin and knees) and ARTHRALGIA (total body arthritic pain,arthritic pain was most  pronounced around my pelvis and knees) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. It was reported that patient had a low grade fever, headache, body aches, chills which were most persistent for 48 hours but lasted for 5 days. Treatment medications were not provided.   This case was linked to MOD-2022-650991, MOD-2022-650998 (Patient Link).
Hives, redness, severe swelling at inj site. Flu like sx now.
Patient was given a flu shot and while ringing her up at the register, patient fainted and fell down. With the help of a customer she was helped out to a chair in the waiting room area. She was feeling dizzy and sweating. EMS arrived in 15 mins and monitored her. She signed off she is fine and they left after 20 minutes. Patient left after 30 mins.
Rash Injection Site Post First Dose; Sore Arm Injection Site Post First Dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore Arm Injection Site Post First Dose) and VACCINATION SITE RASH (Rash Injection Site Post First Dose) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm Injection Site Post First Dose). On 10-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash Injection Site Post First Dose). On 06-Jan-2021, PAIN IN EXTREMITY (Sore Arm Injection Site Post First Dose) had resolved. On 13-Jan-2021, VACCINATION SITE RASH (Rash Injection Site Post First Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided. No treatment information provided.   This case was linked .
I lost my sense of smell and taste for 1 day. I was tested for Covid 3 times, all coming back with a negative result. The senses came back the next morning.
Myalgia, Fever, Chills Narrative: Patient called to report she received her Covid vaccination on 1/6/2021 right arm. She reports she developed chills last night, body aches and her temp has been running between 100.0 to 100.4. She states at either 3am or 4am it it was 100.4. She states she has taken Aleve and her temp this am is 100.0. She states she is home Teleworking this am and will not be working this pm. Encouraged patient to stay hydrated/rest and to continue with her current medication regimen. Advised patient should her symptoms worsen or develop new symptoms to call her Primary Care Provider and or report to the Urgent Care/ER. Patient to call with any questions/concerns. Patient voiced an understanding.
fainted, out for several seconds, recovered. Layed on floor in rescue position for 15 minutes, then left store.  telaphoned 30 minutes later, patient said they were fine
Large red, warm, tender skin rash at injection site appearing morning after injection. Today is 3rd day having rash.
04/12-rash on right arm and now on entire body cont. to itch, did use body powder prior to rash outbreak. Used Benadryl 04/12/05 improved but recurring @ present call into PCP . 04/14/05-Area  bumps scabbed over, MD told her to take typhoid as directed.
Patient received these vaccines post excursion; No Adverse event; Patient received these vaccines post excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received these vaccines post excursion), POOR QUALITY PRODUCT ADMINISTERED (Patient received these vaccines post excursion) and NO ADVERSE EVENT (No Adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 049D22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Nov-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received these vaccines post excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received these vaccines post excursion) and NO ADVERSE EVENT (No Adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received these vaccines post excursion), POOR QUALITY PRODUCT ADMINISTERED (Patient received these vaccines post excursion) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received these vaccines post excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient received these vaccines post excursion).    No concomitant medications were reported.  The nurse reported that, there was temperature excursion on 01-Nov-2022 in the refrigerator. At the time of excursion, the vials were in refrigerated storage. It was individual vials and vial size was unknown. The maximum or minimum temperatures reached at time of excursion was minimum 34.8 F (Fahrenheit) and maximum at 42.49 F  for 14 Minutes duration. The vials were moved from freezer to refrigerator in less than 30 days. On visual inspection vials were in normal state. The patient received the vaccine post excursion and remaining vials were discarded.   No treatment medications were reported.
TWO DAYS AFTER RECEIVING THE MODERNA BIVALENT VACCINE, PATIENT CALLED THE PHARMACY TO LET US KNOW THAT SHE HAS A 2"X2" RED AND RAISED RASH/HIVES AT THE INJECTION SITE. SHE STATES THAT THIS HAS HAPPENED BEFORE AFTER A PREVIOUS COVID VACCINATION. PATIENT COMPLAINS OF ITCHINESS AND STATES THAT SHE TOOK BENADRYL AND IT HELPED.
Inflammation on the injection site; "kind of red" on the injection site; "itchy" on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INFLAMMATION (Inflammation on the injection site), INJECTION SITE ERYTHEMA ("kind of red" on the injection site) and INJECTION SITE PRURITUS ("itchy" on the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE INFLAMMATION (Inflammation on the injection site), INJECTION SITE ERYTHEMA ("kind of red" on the injection site) and INJECTION SITE PRURITUS ("itchy" on the injection site). At the time of the report, INJECTION SITE INFLAMMATION (Inflammation on the injection site), INJECTION SITE ERYTHEMA ("kind of red" on the injection site) and INJECTION SITE PRURITUS ("itchy" on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Patient fainted within a minute of receiving vaccine. Pale, diaphoretic, nauseated. No treatment. Recovered without incident.
Information has been received from a 33 year old female physician for the Merck Pregnancy Registry for GARDASIL, with hypothyroidism and no known drug allergies, who on 01-OCT-2007 was vaccinated intramuscularly into the deltoid with a first dose of GARDASIL.  Concomitant medication included SYNTHROID.  The patient reported that her last menstrual period was 18-SEP-2007 and she ovulated and conceived 03-OCT-2007.  The patient sought unspecified medical attention with another physician.  A pregnancy test was performed.  On 17-JAN-2007 amniocentesis performed at 16 weeks reported that cytomegalovirus, enterovirus and Toxoplasma were not detected.  She went into preterm labor at 34 weeks on 18-MAY-2008 and delivered her daughter by cesarean section at 17:02, weight 400 grams.  She reported that she did not experience any other problems with her pregnancy (except an elevated Downs syndrome risk for which she had the amniocentesis).  She does not think that the vaccine had anything to do with her preterm labor.  Placenta pathology report indicates a third trimester placenta at 34 weeks gestation with subchorionic fibrin deposition and less than 5% of placental disc.  Also noted were microcalcifications, intraparenchymal hemorrhage, no acute chorioamnionitis, and a trivascular umbilical cord.  On 19-MAY-2008 the patient recovered.  No product quality complaint was involved.  Upon internal review preterm labor at 34 weeks delivering by cesarean section was considered to be an other important medical event.  Additional information has been requested.
Extreme headache for 3 days, vomiting, diarrhea, fainting Wednesday 7/06/2022, left arm swelling, fever in arm and redness for 7 days. Bruising on right arm, chin & small lip cut from fall when fainted.
As I received the shot I developed a sensation of painful cold in what felt to be my arm bone immediately above my elbow and my elbow joint. Additionally, immediately following the shot I felt faint, and advised the provider of such.  She said it wasn't an issue and I went out to sit 15 minutes before leaving. That night I awoke to extreme pain in my hip joints. Since that time I have experienced, though diminishing, random pain in my elbow, shoulder, hips and knee that come and go without rhyme or reason. Despite having issues with arthritis, I never had that extreme pain until that night. And for a couple of months after, would experience moderate discomfort and mobility weakness especially when going up and down stairs. This was a year ago, I did initially indicate on the on-line system that I had a negative experience, but then my connection shut down and failed to continue to work. I called for technical assistance, but it failed again. After that, I quit trying. There didn't seem to be much concern. Now I am trying to recall accurately, and have done so to the best of my ability. I didn't make notes as the medical staff I spoke with didn't seem to feel it was anything serious.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 1805025, expiry: unknown) dose was not reported, 1 total, administered on 10-MAR-2021 to left arm for prophylactic vaccination.  No concomitant medications were reported.  On an unspecified date in APR-2021, the patient got a covid-19 infection (coded to suspected covid-19 infection and suspected clinical vaccination failure). The patient stated that, covid-19 was a mild and treated at home with vitamins and treatment medications included: Pedialyte (calcium chloride/glucose/magnesium chloride/potassium chloride/sodium chloride/sodium lactate) and vitamins. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000203066. This case, from the same reporter is linked to 20211142112.; Sender's Comments: V0:20211142018-covid-19 vaccine ad26.cov2.s- suspected clinical vaccination failure . This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Flu-like weakness, pins and needles, tingling feelings, difficulty staying warm, sensitivity to touch (like when you're sick and just sitting on a hard chair is painful). Symptoms subsided somewhat, and then after each shot (cause it takes 3 for Gardasil) was administered they would come back. 1 year after having the last shot I found I no longer had symptoms. Pain and weakness/tingling/pins and needles especially at the injection site, not necessarily when the rest of the body had the same symptoms. I also found that these vaccinations became progressively more painful - the first one hurt more than vaccines or shots usually do, the second one was worse and the third was like "holy fucking shit, are you injecting me with acid?" - I have a high pain tolerance too so I'm not just bitching.
Brain fog Sleeping 20 hours a day Extreme fatigue Cerebral stroke resulting in loss of movement in limbs, trouble with speech
first dose of Pfizer-Biontech Covid19 vaccine on 22Jan2021/ 03Feb2021 of a runny nose/ covid19 test (06Feb2021)/ it came back positive, this morning (08Feb2021); first dose of Pfizer-Biontech Covid19 vaccine on 22Jan2021/ 03Feb2021 of a runny nose/ covid19 test (06Feb2021)/ it came back positive, this morning (08Feb2021); This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program.  A 71-year-old male patient (also age at vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL9262, expiry date: May2021), intramuscular on 22Jan2021 at SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient received his first dose of Pfizer-Biontech Covid19 vaccine on 22Jan2021 and due his second COVID shot tomorrow (09Feb2021). The wife started feeling ill 26Jan2021 and she thought just had sinus infection but she went Sunday 31Jan2021 and had a swab test done and she got swabbed then Monday (results 01Feb2021) she found out she was positive for COVID. The patient took a rapid test that same Monday (01Feb2021) and the rapid test was negative. He reports Covid symptoms on 03Feb2021 of a runny nose-no fever, chills, or diarrhea. He went for a second saliva-based covid19 test (06Feb2021: confirmed by the patient), and it came back positive, this morning (08Feb2021). It was added that the patient had not showed any symptoms through all that time until 03Feb2021 he had a runny nose for one afternoon and that was it and so with the second vaccine on the 09Feb2021 and him being exposed he thought he would get a test Saturday (06Feb2021), he had a saliva test and he got the results today that unfortunately were positive but he still hasn't showed any symptoms other than a runny nose for one afternoon. he has not had  fever or none of the flu like symptoms. He is asking for some information he is hoping for anyway. The patient asked if he should go ahead to get the second shot. and he's looking for guidance on getting his second vaccine dose, tomorrow, or not? What is the recommended interval? What if he waits 4 weeks? He is wondering what to do about 2nd dose, as he is concerned with the timeline. The outcome of the events was unknown.
Information has been received from a Licensed Practical Nurse concerning an 89 year old male patient who on 25-FEB-2011 was vaccinated with a dose (nurse believes that this was his second dose) of PNEUMOVAX 23 (route and lot # unspecified). The nurse reported that on 26-FEB-2011, the patient developed an injection site reaction of swelling and redness and he developed a fever. As treatment, the patient received TYLENOL suppositories, BACTRIM and MEDROL. The nurse reported that his fever "this morning" (on 01-MAR-2011) was 99.8, which she said was "better than it was". The patient being screened for influenza and results were still pending. At the time of the report the patient was recovering. Patient sought unspecified medical attention. Follow up information has been received from a licensed practical nurse concerning a male elective engineer with no pertinent medical history and no drug reactions or allergies who on 25-FEB-2011 was vaccinated in his left arm (deltoid) with a dose of PNEUMOVAX 23 (route not reported). Lot number (9874408) is an invalid lot number for PNEUMOVAX 23. The nurse reported that the patient had the vaccine before but his wife did not remember the date. On 27-FEB-2011 at 10:00 the patient developed a fever of 99.9 axillary, APAP 650mg orally was given. At 14:15 the patient developed a fever of 100.8 axillary. APAP 650 mg orally was given. At 20:00 the patient developed a fever of 101.4 axillary, the site was red and mild edema. Ice pack was applied. On 28-FEB-2011 at 24:00 the patient developed a fever of 100.1, APAP 650 mg orally was given. At 5 the patient developed a fever of 101.3, APAP suppository 650 mg was administered. Treatment for the adverse events included BACTRIM DS for seven days, TAMIFLU 75 mg twice a day for two days and medicine dose as during effects. Conflicting information has been received from Licensed Practical Nurse who reported that fever and cellulitis spreading from the injection site to near shoulder down to the elbow area as illness at time of vaccination and previously reported as adverse events. Influenza testing became positive shortly after fever onset. At the time of the report, the patient recovered from cellulitis and pyrexia on 03-MAR-2011. Additional information has been requested.
On 1/30 Mother called Health Dept at 8:20 AM to report Barret's arm is swollen and hard about a hand's span out from site of shot. No other symptoms and child does not complain with arm. 1/31/03  contact with mother this PM. States child is fine-arm okay.
This is a spontaneous report from a contactable other healthcare professional (patient). A 28-year-old female patient received the first dose of bnt162b2 (COVID-19, brand: Pfizer) via an unspecified route of administration in left arm on 17Jan2021 15:30 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant. The patient had no COVID prior to vaccination and was not COVID tested post vaccionation. There were no concomitant medications. No other vaccine in four weeks. The patient previously took trazodone and tramazole and experienced allergies to both. On 17Jan2021 16:00, the patient experienced severe headache and nausea. Treatment was not given to events. The patient had not recovered from the events. Information on the Lot/Batch number has been requested.
Numbness in legs, lips and Rt. side of face, shortness of breath, chest pain, symptoms happened about 2 hours after immunization, numbness on lips and Rt. side of face still happens occassionally, along with chest pain. pt. states ER MD said high risk of blood clots.  6/29/09 Hospital ER records received DOS 4/28/08. Assessment: Pleuritic chest pain. Patient presented with shortness of breath and chest pain. Worsened deep breathing. Analgesics and steroids administered. Discharged.
3-4 hrs p/vax had fever 102 ax; vomiting/diarrhea; twitching, rolling eyes back for a few seconds (<30 seconds);
Red itchy hot rash at injection site- continued to spread down side of arm to elbow joint. Most uncomfortable in early morning hours 2-6AM.  It began 8-9 days after injection. It has started to lessen in redness, and itch and has stopped spreading.
Immediately after administration, the pt had generalized erythema on the right forearm, ice pack applied and observed for 20 mins. No additional swelling noted, instructed the mother to keep applying ice pack remainder of the day.
Please read all pages enclosed herewith. Check Dr's date against insurance correct info. Dr. reports wrong dates/wrong arm.
C/o severe tightness all muscles, especially lower extremities-OTC Motrin provides tempory relief but must be taken q 3-4 hrs.
The affected area is about the size of a golf ball; Itching at injection site; Swelling at injection site; Hot and red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (The affected area is about the size of a golf ball), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Hot and red at injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE REACTION (The affected area is about the size of a golf ball), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Hot and red at injection site). At the time of the report, VACCINATION SITE REACTION (The affected area is about the size of a golf ball), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Hot and red at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment medication was not reported by the reporter.